Nothing To Sneeze At: Real-time Pollen Forecasts - Journal Analytical Chemistry

Nothing To Sneeze At: Real-time Pollen Forecasts - Journal Analytical Chemistry
Researchers in Germany are reporting an advance toward development of technology that could make life easier for millions of people allergic to plant pollen. It could underpin the first automated, real-time systems for identifying specific kinds of allergy-inducing plant pollen circulating in the air. Their study is in the current issue of ACS' Analytical Chemistry, a semi-monthly journal.

NY City Health Department Launches Effort To Study Neighborhood Air Quality
The Health Department today announced the launch of the New York City Community Air Survey, the first comprehensive effort to monitor street level air pollution in neighborhoods across the five boroughs. Air pollution monitors mounted on 150 light posts throughout the city will be used to measure major air pollutants that contribute to health problems.

Sucampo Initiates Phase 1 Study Of SPL-017 For Peripheral Arterial Disease

Sucampo Pharma, Ltd., of Japan, a wholly-owned subsidiary of Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP), today announced that it has initiated dosing in a first-in-human clinical safety study of a proprietary prostone, SPL-017, as a potential treatment for peripheral arterial disease (PAD). The randomized, double-blind, placebo-controlled, single-center, single ascending dose study will evaluate the safety and pharmacokinetic profile of SPL-017. Complete news at...

Researchers in Germany are reporting an advance toward development of technology that could make life easier for millions of people allergic to plant pollen. It could underpin the first automated, real-time systems for identifying specific kinds of allergy-inducing plant pollen circulating in the air. Their study is in the current issue of ACS' Analytical Chemistry, a semi-monthly journal. Complete news at...